[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577035":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":40,"collaborators":19,"id":44,"slug":19,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":16,"eligibilityCriteria":48,"healthyVolunteers":45,"sex":49,"minAge":50,"maxAge":19,"enrollmentInfo":51,"targetDuration":19,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":19,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Jacobs institute","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"SHIELD Study Arm","Active treatment with the Pipeline SHIELD Device",[12],"Device: SHIELD",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","SHIELD","Pipeline SHIELD device under study",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Carlos Pena, PhD, MS","CONTACT","2404810824","cpena@jacobsinstitute.org",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":19},"Jacobs Institute","RECRUITING","Buffalo","New York","14203","United States",{"type":35,"coordinates":36},"Point",[37,38],-78.87837,42.88645,{"lat":38,"lon":37},{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Elad Levy","Principal Investigator","100577035",false,"NCT06793059","Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)","Inclusion Criteria:\n\n* Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.\n\nExclusion Criteria:\n\nExclusion Criteria:\n\n* Cannot provide consent or legally authorized representative not available to provide consent Criteria:","ALL","22 Years",{"count":52,"type":53},10,"ESTIMATED","INTERVENTIONAL",[56],"NA","The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms",[59],"Aneurysm","2026-03-06",{"date":62,"type":63},"2026-03-10","ACTUAL",{"date":65,"type":63},"2025-01-01",{"date":67,"type":53},"2027-01-01",{"name":5,"class":6},1]